| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 02/21/2008 | US20080044450 Sustained Release Composition |
| 02/21/2008 | US20080044436 Method for Screening and Compositions for Treating Cancers |
| 02/21/2008 | US20080044435 Tat-Based Tolerogen Compositions and Methods of Making and Using Same |
| 02/21/2008 | US20080044432 Mammalian receptor proteins; related reagents and methods |
| 02/21/2008 | US20080044431 Therapeutic formulations containing venom or venom anti-serum either alone or in combination for the therapeutic prophylaxis and therapy of neoplasms |
| 02/21/2008 | US20080044428 Glycosylphosphatidylinositol Glycan Signalling Via Integrins Functioning as Glycan Specific Receptors |
| 02/21/2008 | US20080044425 Polypeptides having phospholipase a2 activity |
| 02/21/2008 | US20080044422 CNGH0010 Specific Polynucleotides, Polypeptides, Antibodies, Compositions, Methods and Uses |
| 02/21/2008 | US20080044421 Methods of using death receptor ligands and CD20 antibodies |
| 02/21/2008 | US20080044419 Treatment of T Cell Mediated Diseases by Inhibition of Fgfr3 |
| 02/21/2008 | US20080044412 Single-Domain Antibody Strengthening Fusion Protein Vh-Ldp-Ae |
| 02/21/2008 | US20080044411 Human glp-1 mimetibodies, compositions, methods and uses |
| 02/21/2008 | US20080044409 Inflammatory mediator antagonists |
| 02/21/2008 | US20080044404 Annexin V for Preventing Atherothrombosis and Plaque Rupture |
| 02/21/2008 | US20080044401 Drug therapy for celiac sprue |
| 02/21/2008 | US20080044400 Targeted enzyme prodrug therapy |
| 02/21/2008 | US20080044399 Vitamin E supplementation for reducing cardiovascular events in individuals with DM and the Hp 2-2 genotype |
| 02/21/2008 | US20080044398 Soluble composition having enzymatic activity and improved stability |
| 02/21/2008 | US20080044397 Compositions to reduce or prevent skin cancer |
| 02/21/2008 | US20080044394 Methods for genetic modification of hematopietic progenitor cells and uses of the modified cells |
| 02/21/2008 | US20080044387 Artificial niches for enhancement of regenerative capacity of stem cells in aged and pathological environments |
| 02/21/2008 | US20080044386 Protamine-Adenoviral Vector Complexes and Methods of Use |
| 02/21/2008 | US20080044385 Novel Modified Galectin 8 Proteins and Use Thereof |
| 02/21/2008 | US20080044382 Methods of treating inflammatory and autoimmune diseases with alpha-4 inhibitory compounds |
| 02/21/2008 | US20080044381 Stable liquid interferon formulations |
| 02/21/2008 | US20080044380 Hepatitis C Virus Inhibitors |
| 02/21/2008 | US20080044379 (1R)-2-((2S)-2-(5-(6-(4-(2-((2S)-1-((2R)-2-(dimethylamino)-2-phenylacetyl)-2-pyrrolidinyl)-1H-imidazol-5-yl)phenyl)-3-pyridinyl)-1H-imidazol-2-yl)-1-pyrrolidinyl) -N,N-dimethyl-2-oxo-1-phenylethanamine; inhibit the function of the non-structural proteins (NS5A) |
| 02/21/2008 | US20080044378 Methods and Compositions for Protein Production Using Adenoviral Vectors |
| 02/21/2008 | US20080044377 Poxvirus Vector Encoding Retrovirus (Eg Hiv) And Cytokine |
| 02/21/2008 | US20080044376 Cytokine Design |
| 02/21/2008 | US20080042818 Trailer tire alert system |
| 02/21/2008 | DE102007004991A1 Use of biocomplex preparation (from reaction pattern in vertebrate cells) for the treatment of apoplexia and acute circulatory disorders |
| 02/21/2008 | DE102006038252A1 Zubereitung mit marinem Kollagen zur Proteinasehemmung Preparation with marine collagen to Proteinasehemmung |
| 02/21/2008 | CA2661193A1 Therapeutic methods for neuropathic pain |
| 02/21/2008 | CA2661014A1 Cardioprotective compounds |
| 02/21/2008 | CA2660902A1 Methods for reducing toxicities associated with medical procedures employing radiographic contrast agents |
| 02/21/2008 | CA2660516A1 Treating or preventing cancers over-expressing reg4 or kiaa0101 |
| 02/21/2008 | CA2660294A1 Diuretic and natriuretic polypeptides |
| 02/21/2008 | CA2660178A1 Promiscuous her-2/neu cd4 t cell epitopes |
| 02/21/2008 | CA2660128A1 Glycan data mining system |
| 02/21/2008 | CA2660064A1 Promiscuous pap cd4 t cell epitopes |
| 02/21/2008 | CA2659655A1 Salicylanilides enhance oral delivery of therapeutic peptides |
| 02/21/2008 | CA2659585A1 Inhibition of angiogenesis, tumorigenesis and cathepsin activity using insulin-like growth factor binding protein |
| 02/21/2008 | CA2658564A1 Treatment of ocular diseases |
| 02/20/2008 | EP1890150A1 Determination of agonistic autoantibodies associated with humoral kidney rejection |
| 02/20/2008 | EP1889915A1 APO-2 ligand |
| 02/20/2008 | EP1889914A1 Compositions for gene therapy of diabetes |
| 02/20/2008 | EP1889913A1 Transcription factor islet-brain 1 (IB1) |
| 02/20/2008 | EP1889912A1 Transcriptions Factor Islet-Brain 1 (IB1) |
| 02/20/2008 | EP1889911A2 An antisense oligonucleotide preparation method |
| 02/20/2008 | EP1889908A1 Anti-cd14 antibody-fused protein |
| 02/20/2008 | EP1889905A1 Method for amelioration of disease condition induced by mood disorder |
| 02/20/2008 | EP1889838A1 Thrombopoietin mimetics |
| 02/20/2008 | EP1889639A2 Methods and compositions containing succinimide or maleimide derivatives of antineoplastic agents, for producing long lasting antineoplastic agents |
| 02/20/2008 | EP1889633A1 Medicinal compositions for angiogenic therapy |
| 02/20/2008 | EP1889631A1 Cell growth inhibition |
| 02/20/2008 | EP1889629A1 Stable formulation comprising a combination of a moisture sensitive drug and a second drug and manufacturing procedure thereof |
| 02/20/2008 | EP1889628A1 Lipid liposome composition |
| 02/20/2008 | EP1889627A1 Therapeutic agent for blood-related disease containing epo derivative |
| 02/20/2008 | EP1889626A1 Hip kinase for fertility control |
| 02/20/2008 | EP1889618A1 Combined drug for treating diabetes |
| 02/20/2008 | EP1889547A2 A food composition and method of using same |
| 02/20/2008 | EP1889058A1 Diagnosis and treatment of endometriosis |
| 02/20/2008 | EP1888769A2 Methods and compositions for using alveolar macrophage phospholipase a2 |
| 02/20/2008 | EP1888762A1 Isolated dipeptides with ace inhibitor effect |
| 02/20/2008 | EP1888633A2 Evolved interferon-alpha polypeptides |
| 02/20/2008 | EP1888632A2 Cytokine |
| 02/20/2008 | EP1888629A2 Neuritogenic peptides |
| 02/20/2008 | EP1888628A1 A peptide ligand to impair cancer cell migration |
| 02/20/2008 | EP1888626A2 A therapeutic agent for ab related disorders |
| 02/20/2008 | EP1888624A2 Method of purifying apo-2 ligand/trail using crystallisation in the cold |
| 02/20/2008 | EP1888118A1 Stabilized polypeptide formulations |
| 02/20/2008 | EP1888117A1 Stabilized polypeptide formulations |
| 02/20/2008 | EP1888112A2 Psk-1 and its modulators for the treatment/diagnosis of cancer |
| 02/20/2008 | EP1888111A1 Modulation of cholesteryl ester transfer protein (cetp) activity |
| 02/20/2008 | EP1888106A2 Compositions and methods for treating conditions related to ephrin signaling with cupredoxins |
| 02/20/2008 | EP1888104A2 Acylated insulin with high purity |
| 02/20/2008 | EP1888103A2 Use of glp-1, exendin and agonists thereof to delay or prevent cardiac remodeling |
| 02/20/2008 | EP1888102A2 Modulation of peripheral clocks in adipose tissue |
| 02/20/2008 | EP1888101A2 Compositions and methods for lipo modeling |
| 02/20/2008 | EP1888100A2 Use of il-18bp isoforms for the treatment and/or prevention of neurological inflammatory diseases |
| 02/20/2008 | EP1888099A2 Hydratable keratin compositions |
| 02/20/2008 | EP1888098A2 Glycopegylated erythropoietin formulations |
| 02/20/2008 | EP1888097A1 Fk 228 derivates as hdac inhibitors |
| 02/20/2008 | EP1888096A2 Milk fat globule epidermal growth factor-factor viii and sepsis |
| 02/20/2008 | EP1888095A2 Modulators of alpha-synuclein toxicity |
| 02/20/2008 | EP1888094A2 Amylin and amylin agonists for treating psychiatric diseases and disorders |
| 02/20/2008 | EP1888085A1 Methods for providing palliative care with avr118 |
| 02/20/2008 | EP1888052A2 Blockade of pin1 prevents cytokine production by activated immune cells |
| 02/20/2008 | EP1888049A2 Localized delivery of cardiac inotropic agents |
| 02/20/2008 | EP1888031A1 Glp-1 analogue formulations |
| 02/20/2008 | EP1589992A4 Method for treating elevated intraocular pressure, including glaucoma |
| 02/20/2008 | EP1578294A4 Methods and systems for enabling and stabilizing tooth movement |
| 02/20/2008 | EP1406667B1 Methods for increasing in vivo efficacy of oligonucleotides and inhibiting inflammation in mammals |
| 02/20/2008 | EP1404704B9 Bridged bicyclic serine protease inhibitors |
| 02/20/2008 | EP1359936B1 Combined use of factor vii polypeptides and factor viii polypeptides |
| 02/20/2008 | EP1289548B1 Immune system stimulating means |
| 02/20/2008 | EP1225915B1 Use of anti-il-2 polyclonal antibodies for the treatment of insulin-dependent diabetes mellitus and lupus erythematosus |
| 02/20/2008 | EP1194170B1 Growth hormone formulations |
| 02/20/2008 | EP1163349B1 Medical preparations for the treatment of alpha-galactosidase a deficiency |